Hematuria News and Research

RSS
In medicine, hematuria, or haematuria, is the presence of red blood cells (erythrocytes) in the urine. It may be idiopathic and/or benign, or it can be a sign that there is a kidney stone or a tumor in the urinary tract (kidneys, ureters, urinary bladder, prostate, and urethra), ranging from trivial to lethal.
Findings explain why women with bladder cancer are often diagnosed at later stage than men

Findings explain why women with bladder cancer are often diagnosed at later stage than men

Janssen submits supplemental New Drug Application for IMBRUVICA to the U.S. FDA

Janssen submits supplemental New Drug Application for IMBRUVICA to the U.S. FDA

Prostate cancer breakthroughs offer new hope for men

Prostate cancer breakthroughs offer new hope for men

Astellas, Medivation submit European Marketing Authorization Application for XTANDI capsules

Astellas, Medivation submit European Marketing Authorization Application for XTANDI capsules

CSI's new Diamondback Peripheral 60cm systems receive FDA clearance for PAD treatment

CSI's new Diamondback Peripheral 60cm systems receive FDA clearance for PAD treatment

Pharmacyclics total revenue for fourth quarter 2013 increases 113% to $123.6 million

Pharmacyclics total revenue for fourth quarter 2013 increases 113% to $123.6 million

Chesapeake Urology for Kids introduced for pediatric care

Chesapeake Urology for Kids introduced for pediatric care

FDA approves Farxiga tablets to improve glycemic control in adults with type 2 diabetes mellitus

FDA approves Farxiga tablets to improve glycemic control in adults with type 2 diabetes mellitus

Emergent BioSolutions enters into definitive agreement to acquire Cangene

Emergent BioSolutions enters into definitive agreement to acquire Cangene

Pharmacyclics presents ibrutinib trial data for B-cell malignancies at ASH meeting

Pharmacyclics presents ibrutinib trial data for B-cell malignancies at ASH meeting

EC grants marketing authorization for XTANDI capsules for treating advanced prostate cancer

EC grants marketing authorization for XTANDI capsules for treating advanced prostate cancer

Study shows GreenLight laser therapy effective for BPH treatment

Study shows GreenLight laser therapy effective for BPH treatment

Astellas submits application for marketing approval of enzalutamide for prostate cancer

Astellas submits application for marketing approval of enzalutamide for prostate cancer

Study estimates ER costs for hematuria patients at more than $237 million a year

Study estimates ER costs for hematuria patients at more than $237 million a year

Biogen Idec, Sobi release data from rFVIIIFc and rFIXFc phase 3 trials on hemophilia

Biogen Idec, Sobi release data from rFVIIIFc and rFIXFc phase 3 trials on hemophilia

Delayed hematuria common after prostate brachytherapy

Delayed hematuria common after prostate brachytherapy

Microscopic hematuria poor indicator for renal, bladder malignancy

Microscopic hematuria poor indicator for renal, bladder malignancy

FDA approves Takeda’s NESINA, OSENI and KAZANO for treatment of type 2 diabetes

FDA approves Takeda’s NESINA, OSENI and KAZANO for treatment of type 2 diabetes

Study reports on development and testing of Hematuria Risk Index to predict cancer risk

Study reports on development and testing of Hematuria Risk Index to predict cancer risk

Canine lymphoma treatment adds up to cystitis

Canine lymphoma treatment adds up to cystitis